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Abstract
Highly pathogenic avian influenza A viruses (HPAIV) of the H5N1 subtype occasionally transmit from birds to humans and
can cause severe systemic infections in both hosts. PB1-F2 is an alternative translation product of the viral PB1 segment that
was initially characterized as a pro-apoptotic mitochondrial viral pathogenicity factor. A full-length PB1-F2 has been present
in all human influenza pandemic virus isolates of the 20th century, but appears to be lost evolutionarily over time as the new
virus establishes itself and circulates in the human host. In contrast, the open reading frame (ORF) for PB1-F2 is exceptionally
well-conserved in avian influenza virus isolates. Here we perform a comparative study to show for the first time that PB1-F2
is a pathogenicity determinant for HPAIV (A/Viet Nam/1203/2004, VN1203 (H5N1)) in both mammals and birds. In a
mammalian host, the rare N66S polymorphism in PB1-F2 that was previously described to be associated with high lethality
of the 1918 influenza A virus showed increased replication and virulence of a recombinant VN1203 H5N1 virus, while
deletion of the entire PB1-F2 ORF had negligible effects. Interestingly, the N66S substituted virus efficiently invades the CNS
and replicates in the brain of Mx+/+ mice. In ducks deletion of PB1-F2 clearly resulted in delayed onset of clinical symptoms
and systemic spreading of virus, while variations at position 66 played only a minor role in pathogenesis. These data
implicate PB1-F2 as an important pathogenicity factor in ducks independent of sequence variations at position 66. Our data
could explain why PB1-F2 is conserved in avian influenza virus isolates and only impacts pathogenicity in mammals when
containing certain amino acid motifs such as the rare N66S polymorphism.
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Introduction
Direct bird-to-human transmission of highly pathogenic avian
influenza A viruses (HPAIV) of the H5N1 subtype was first
reported in 1997 [1]. Since then, 518 human cases have been
confirmed (WHO: updated January 20th, 2011). Unlike seasonal
influenza A viruses, HPAIVs do not yet have the ability to spread
directly from human-to-human, a likely consequence of multiple
species barriers, including their preferential attachment to alpha
2,3-linked sialic acids which are rarely present in the upper regions
of the human respiratory tract [2]. However, human infections
with these viruses often clinically manifest with an unusual
hyperactivation of the host immune response, vast overproduction
of cytokines and chemokines, severe inflammatory response
syndrome, fever, pneumonia, pulmonary hemorrhage, acute
respiratory distress syndrome, lymphopenia, prominent hemopha-
gocytosis, disseminated intravascular thrombosis, diarrhea and
multiorgan failure [3,4,5,6,7]. Despite the low number of cases so
far, the overall human mortality rate of HPAIV (,60%, WHO:
updated January 20th, 2011) is of serious concern, and the
possibility that these HPAIVs might reassort with a circulating
human strain, thereby potentially integrating lethality and
transmissibility, is a continuous public-health risk.
Waterfowl, particularly ducks, are an important natural reservoir
for a variety of influenza A viruses [8]. Infections with low
pathogenic avian influenza A virus are usually asymptomatic in
ducks [9]. The virus mainly replicates in enterocytes in the digestive
tract of infected animals and is shed in the feces [10,11]. Even most
HPAIV infections only cause mild clinical signs in ducks and
immune competent animals usually recover from infection [12]. In
contrast, chickens often die abruptly by infection with HPAIV.
Despite similar multi-organ tropism in ducks and chicken, HPAIV
apparently replicates better in chicken, as higher viral titers are
commonly observed [12]. Exceptions to this are clade 2.2 H5N1
HPAIVs, which cause death in experimentally infected ducks [13].
PB1-F2 was identified ,10 years ago during the screening of
MHC presented epitopes of alternative ORF gene products from
influenza A virus infected cells [14]. This 90 amino acid
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polypeptide is translated from the PB1 mRNA from an alternative
start codon in the +1 reading frame, approximately 100 base pairs
downstream of the PB1 start codon. Initially PB1-F2 was
characterized as a pro-apoptotic peptide, integrating into the
inner mitochondrial membrane and disrupting mitochondrial
membrane potential, apparently with a preference for monocytic
cells [14,15,16,17]. In this regard, later studies showed that PB1-
F2 can interact with the mitochondrial membrane proteins
VDAC-1 and ANT3 [18], both of which are involved in
maintaining the mitochondrial membrane potential [19]. For the
mouse-adapted human H1N1 isolate A/PR/8/1934 (PR8), PB1-
F2 can increase the viral polymerase function, presumably due to
its interaction with the polymerase subunit PB1 [20]. Recent
studies have confirmed both the pro-apoptotic and polymerase
enhancing functions of PB1-F2, but have clearly shown that these
activities are highly dependent upon the specific virus isolate used
[21].
With parallels to the current sporadic bird-to-human transmis-
sions of H5N1 HPAIV, the causative agent of the devastating 1918
‘‘Spanish flu’’ (1918 H1N1 virus) was proposed to have originated
in humans as a direct transmission from birds. The PB1-F2 of this
virus is unusual in that it contains a serine at position 66 instead of
asparagine. A recombinant mutant 1918 virus with a substitution
of asparagine for serine at position 66 (S66N) showed increased
MLD50, which was approximately two to three orders of
magnitude higher than for the wild type recombinant virus [22].
The molecular mechanism for enhanced pathogenesis caused by
the 66S polymorphism is not fully understood. However, recent
experiments with PB1-F2 derived peptides suggest that the C-
terminus of PB1-F2, which includes residue 66, can induce
proinflammatory cytokines [23]. In addition, PB1-F2 of
1918:H1N1 has been shown to increase secondary bacterial
infections of mice [24].
Descendents of the 1918 H1N1 virus still circulate in humans to
date, but soon after their introduction into humans they acquired
an asparagine at position 66, and in the early 1950s much of the
PB1-F2 ORF was lost by introduction of a premature stop codon
at position 58, thus leaving the polypeptide without its C-terminal
mitochondrial targeting sequence. Furthermore, an identical
truncation occurred independently in human isolates after the
reintroduction of H1N1 viruses expressing a 90aa PB1-F2 in the
late 1970s. For human H2N2 and H3N2 viruses, the original
pandemic viruses had a PB1 gene derived by reassortment from an
avian influenza virus strain, containing a full-length PB1-F2 ORF.
Recently published data suggest that at least the PB1-F2s encoded
by current human H3N2 viruses might not be functional [21].
Thus, it has been suggested that in humans there is no selective
pressure to maintain full-length and/or functional PB1-F2 and
that PB1-F2 might have a different role in mammalian versus
avian hosts [25]. In this regard, reintroduction of the PB1-F2 ORF
by reverse genetics into the novel 2009 pandemic H1N1 virus did
not significantly increase pathogenicity of this virus in mouse [26].
In stark contrast to the situation in human influenza A viruses, full
length PB1-F2 ORFs are highly conserved in viruses isolated from
avian species [25], especially waterfowl. For example, in duck virus
isolates the prevalence of full length PB1-F2 is almost 96%.
Nevertheless, the role of PB1-F2 in avian species is unknown and
comprehensive studies in avian systems have been limited.
The PB1-F2s of all human influenza A virus pandemics of the
last century were derived from avian strains. In this study, we
compared effects of PB1-F2 expression and sequence variation at
position 66 on viral pathogenesis and host response in two
prototype mammalian and avian model organisms, mice and
ducks. We sought to delineate host dependent functions of PB1-F2
from a highly pathogenic H5N1 avian influenza virus that has
crossed the bird-mammal species barrier and caused severe
infections in both host systems.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with recom-
mendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. All mouse procedures
were approved by Institutional Animal Care and Use Committee
(IACUC) of Mount Sinai School of Medicine and performed in
accordance with the IACUC guidelines (Protocol # LA08-00594:
‘‘Contribution of NS1 to pathogenicity and evasion of innate
immunity’’). Duck experiments were conducted under ABSL-3
conditions in a USDA approved facility and performed according
to protocol R-09-93 ‘‘Transmissibility of Influenza A Viruses’’,
approved by the Institutional Animal Care and Use Committee of
the University of Maryland.
Antibodies and Reagents
A customized polyclonal serum against the N-terminal 37aa of
A/Viet Nam/1203/2004 PB1-F2 was raised in rabbits (Gene-
script). Monoclonal mouse anti-influenza A virus anti-NP (clone
28D8) was generated against RNPs of A/Puerto Rico/8/1934 in
the hybridoma facility of MSSM, NY. Mouse monoclonal
antibody against prohibitin was purchased from Abcam (clone
II-14-10).
Viruses and Cells
All recombinant influenza A/Viet Nam/1203/2004 (VN1203)
viruses and the low pathogenic version thereof were described
previously [27]. The PB1-F2 deletion mutant of this virus was
generated by substitution of bases T96C (in PB1-F2-ORF: ATG-
.ACG), C129G (TCA-.TGA), C198G (TCA-.TGA), T210C
(ATG-.ACG) and T231C (ATG-.ACG) in the PB1 ORF of
pPol1-PB1 A/Viet Nam/1203/2004, thus eliminating all 3 ATGs
and introducing 2 additionally two stop codons in the PB1-F2
Author Summary
Influenza A viruses can infect avian and mammalian hosts.
Human infections with seasonal influenza virus strains are
usually confined to the respiratory tract and are cleared
within days by the immune system. In contrast, highly
pathogenic avian influenza viruses can spread throughout
the whole body, usually resulting in multi-organ failure
and even death in immune competent hosts. Here, we
investigated the species-specific function of an influenza A
virus protein, PB1-F2, that is highly conserved in avian
influenza virus strains but which is lost in many isolates
from mammalian hosts. Our data indicate that PB1-F2
allows successful spreading of the virus throughout the
body in experimentally infected ducks. In contrast, PB1-F2
does not contribute to the severity of HPAIV infections in
mice. Nevertheless, a polymorphism at position 66 of PB1-
F2 (N66S) that was found in the devastating 1918
pandemic virus and in several early H5N1 HPAIV isolates
clearly increased pathogenicity of a HPAIV influenza virus
in mice. Our findings might explain why the whole PB1-F2
ORF is conserved in avian influenza viruses, since it
contributes to viral dissemination and pathogenicity, but
can be lost in mammalian hosts as it has minimal effects
on virulence.
Distinct Role of HPAIV PB1-F2 in Mice and Ducks
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ORF, using the Quick Change Site directed mutagenesis kit
(Stratagene) according to the manufacturer’s instructions. The
PB1-F2 N66S mutant was generated by introducing the A291G
substitution (in PB1-F2-ORF: AAT-.AGT). None of the
mutations result in non-synonymous changes in the ORF of PB1
or N40. The same mutations were introduced into a low
pathogenic mutant of VN1203 lacking the multi-basic cleavage
site of HA (HAlo). All viruses were plaque purified and successful
PB1-F2 mutagenesis was confirmed by sequencing the viral RNA
of stocks used for infection experiments. No additional mutations
were found in any other gene segment of the recombinant viruses .
Madin Darby canine kidney (MDCK) cells, murine lung
epithelial adenoma cells (LA-4) and duck embryonic fibroblasts
(DEF) were purchased from ATCC and cultured according to the
manufacturer’s instructions. Murine bone marrow derived mac-
rophages (BMDMs) were generated and cultured as described
previously [28]. Murine bone marrow derived dendritic cells
(BMDDCs) were isolated as BMDMs, but differentiated in the
presence of recombinant murine GM-CSF at 20 ng/ml (R&D)
[29].
Animal Models
C57/BL/6 mice were purchased from Jackson Laboratories.
C57/BL/6/A2G-Mx1, a mouse line expressing functional Mx1,
was kindly provided by Peter Staeheli, University of Freiburg,
Germany. These mice were generated in a fashion similar to the
previously described BALBc/A2G-Mx1 mice [30]. All viral
infections of mice were performed in accordance with CDC and
USDA guidelines in the ABSL-3+ facility of Mount Sinai School of
Medicine, New York, NY. Briefly, mice were anesthetized by
intraperitoneal injection of ketamine-xylazine and infected intra-
nasally with 50 ml of virus diluted in PBS. The mice were
monitored for clinical signs and weight loss daily. Animals were
humanely euthanized upon reaching 75% of initial body weight.
MLD50 was calculated according to the method of Reed and
Muench. Viral lung titers were determined by standard plaque
assay on MDCK cells [31].
Two-week old White Peking ducks (McMurray Hatchery, IA,
USA) were randomly divided into four treatment groups (n = 16)
and housed in separate isolators. Following the acclimatization
period, animals were mock inoculated with PBS or infected
through natural routes with 104 pfu of the recombinant viruses
diluted in 1 ml PBS (0.5 ml intratracheal, 0.3 ml into the nares,
and 0.2 ml into the eyes). Clinical signs (depression, cyanosis of the
skin, respiratory involvement, diarrhea, edema of the face and/or
head, and neurological signs) were monitored and scored daily. A
pathogenicity index was calculated as previously described [32].
Tracheal and cloacal swabs were taken on days 1, 3 and 5 post-
infection. Viral load of multiple organs were determined on day 1
and 3 post infection using the TCID50 method as described
previously [33].
Quantitative PCR (qPCR) and Primer Sequences
Total RNA was isolated by Qiagen RNeasy Mini Kits (Qiagen)
or TRIzol (Invitrogen) according to the manufacturer’s instruc-
tions. 1–5 mg of total RNA was used for reverse transcription by
oligo-dT priming in a 20 ml volume (1st Strand cDNA synthesis kit,
Roche). 0.5 ml of 1:10 diluted cDNA, 2 ml of 10 mM gene specific
primer mix (sequences for murine cDNAs, duck cDNAs and
influenza segment 7 see Table 1) and 5 ml of 2x SYBR-Green
qPCR Mastermix (Roche) were used for qPCR in a Light-
Cycler480 (Roche). Mean N-fold expression levels of cDNA from
three individual biological samples, each measured in triplicates,
were normalized to 18S rRNA levels and calibrated to mock
treated samples according to the 22DDCT method [34].
Immunofluorescence Microscopy
Immunofluorescence microscopy was performed using a Zeiss
Axioplan fluorescence microscope and Axiovision image acquisi-
tion and analysis software at the MSSM-Microscopy Shared
Resource Facility, supported with funding from NIH-NCI shared
resources grant (5R24 CA095823-04), NSF Major Research
Instrumentation grant (DBI-9724504) and NIH shared instru-
mentation grant (1 S10 RR0 9145-01).
SDS-PAGE and Western Blot Analysis
SDS PAGE and western blot were performed as described
previously [35]. Briefly, total cell lysates were obtained by
collecting adherant and floating cells in disruption buffer
containing 6 M urea, 2 M b-mercaptoethanol and 4% SDS.
Genomic DNA was fragmented by brief sonication on ice. Lysates
were not centrifuged before gel electrophoresis since this method
of disruption does not yield a visible pellet after centrifugation.
Total protein lysates were separated on 4–15% or 4–20% gradient
Ready-Gels (Biorad) and transferred to PVDF membranes for
western blot analysis.
Polymerase Assay
The murine RNA-polymerase I driven negative sense luciferase
reporter plasmid (pcDNA3.1-IVAR-Luc) was cloned by replacing
the CMV promotor of pcDNA3.1 (Invitrogen) with bp -2150 - +1
of the murine 45S ribosomal RNA promotor. We used pMrTsp-9-
T10 plasmid, kindly provided by Dr. Gernoth La¨ngst, University
of Regensburg, Germany, as template for amplification of murine
RNA polymerase I promotor and terminator sequences [36]. A
negatively orientated firefly luciferase coding sequence, flanked by
influenza NP promotor elements was inserted downstream. The
murine RNA Pol1 terminator of 45S ribosomal RNA was
introduced downstream of the negatively oriented reporter gene.
Murine 3T3 fibroblasts were transfected in 24 well format with
50–400 ng of pCAGGS PB1 (VN1203 WT or mutants PB1-F2
generated as described for the recombinant viruses), 100 ng
pCAGGS-PB2 and -PA and 200 ng of pCAGGS-NP (all
VN1203), 100 ng of pcDNA3.1-IVAR-Luciferase and 50 ng of
pCMV-Renilla-luciferase, using Lipofectamin 2000 (Invitrogen)
according to the manufacturers instructions. Cells were lysed 24 h
post transfection according to the manufacturers instruction (Dual
Luciferase Kit Promega). Firefly-Luciferase activity was normal-
ized by Renilla activity. Samples were measured in independent
biological triplicates.
Statistical Analysis
All statistical analyses were performed using GraphPad Prism
Software Version 5.00 (GraphPad Software Inc., San Diego, CA).
Comparison between two treatment means was achieved using a
two-tailed Student t-test, whereas multiple comparisons were
carried out by analysis of variance (ANOVA) followed by
Dunnett’s test using the WT virus as the control. Survival analyses
were carried out following the Kaplan Meier procedure. The
differences were considered statistically significant at p,0.05.
Results
PB1-F2 has been associated with a spectrum of functions within
influenza A virus infected cells. Some of these functions are
believed to be host cell type and/or virus strain specific. To
comparatively study the role of a HPAIV PB1-F2 in both
Distinct Role of HPAIV PB1-F2 in Mice and Ducks
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mammalian and avian hosts, we used reverse genetics to generate
the wild-type recombinant VN/1203/04 (H5N1) (VN1203) virus
(WT), together with a PB1-F2 deficient mutant (dF2) and a
substitution mutant bearing a serine at position 66 (N66S).
VN1203 was selected as this viral strain can efficiently infect both
mice and ducks [37,38], and causes severe disease in these species.
PB1-F2 with the N66S Mutation Increases H5N1 Viral
Replication in Murine Cells
We first studied the replication kinetics of VN1203 WT, dF2
and N66S viruses in the murine lung epithelial adenoma cell-
line LA-4. Although similar or higher levels of viral nucleopro-
tein (NP) were observed for the mutant viruses as compared to
WT, the expression of the N66S mutant form of PB1-F2 was
lower than that of WT and barely detectable at 24 h post
infection (Fig. 1A, panel 2, long exposure). Treatment with
10 mM lactocystin resulted in increased levels of PB1-F2 N66S
but not WT, suggesting specific proteasomal degradation of the
mutant PB1-F2 (Fig. 1B). Interestingly, the N66S substituted
PB1-F2 migrates slower in the gel, possibly indicating a
posttranslational modification. Interestingly, the PB1-F2 defi-
cient virus generates higher amounts of NP 4 h post infection.
These levels adjust to WT at later timepoints, implying an early
deregulation of protein expression. However, deletion of the
PB1-F2 ORF does not change polymerase activity (Fig. 1C) or
viral multi-cycle growth in these cells: the WT and PB1-F2
deficient viruses grow to identical titers. Notably, the N66S
substituted virus grows to 10-fold higher titers than WT or dF2
after 72 h (Fig. 1D).
Previous studies have suggested that PB1-F2 may play a role in
monocytic cells. To address the potential cell-type specific effects
of VN1203 PB1-F2, we infected murine bone marrow derived
macrophages (BMDM) and dendritic cells (BMDDC) as a model
system for monocytic cells (Fig. 1E). Notably, in macrophages and
dendritic cells, we were unable to detect PB1-F2 expression (data
not shown), possibly as a result of low protein stability and/or
lower levels of protein expression. Interestingly, in both these bone
marrow derived cells, the N66S virus appeared to replicate better
than the WT and dF2, as estimated by western blot against viral
nucleoprotein at 8 and 16 h post-infection.
VN1203 PB1-F2 Does Not Predominantly Co-Localize
with Mitochondria
PB1-F2 was initially described to localize predominantly to
mitochondria (as shown for A/Puerto Rico/8/1934 [14]) but also in
the cytoplasm and nucleus [39], depending on the virus strain
studied. The mitochondrial localization and interaction with
mitochondrial membrane proteins VDAC-1 and ANT-3 were
proposed to be the basis for the PB1-F2 pro-apoptotic function [18].
Since the N66S substitution is localized in close proximity to the
mitochondrial localization sequence, we tested whether this
substitution alters the sub-cellular localization of VN1203 PB1-F2
in mouse epithelial cells. By immunofluorescent staining of LA-4
murine lung epithelial cells infected with the WT, dF2 or N66S
mutants of VN1203, we could detect WT PB1-F2 as early as 8 h p.i.
(Fig. S1A, panel 2). At 4 h p.i. no PB1-F2 specific signal was
detectable (data not shown). In agreement with our western blot
data the N66S substituted PB1-F2 was not detectable at 8h p.i.. WT
Table 1. qPCR primers for murine and duck cDNAs and influenza segment 7.
mouse gene forward (59 -39) reverse (59 -39)
IL1beta GCAACTGTTCCTGAACTCAACT ATCTTTTGGGGTCCGTCAACT
IL18 GACTCTTGCGTCAACTTCAAGG CAGGCTGTCTTTTGTCAACGA
IFNbeta CAGCTCCAAGAAAGGACGAAC GGCAGTGTAACTCTTCTGCAT
Mx1 GACCATAGGGGTCTTGACCAA AGACTTGCTCTTTCTGAAAAGCC
IFNgamma TGCTGATGGGAGGAGATGTCTAC TTTCTTTCAGGGACAGCCTGTTAC
IL6 TGAGATCTACTCGGCAAACCTAGTG CTTCGTAGAGAACAACATAAGTCAGATACC
ISG15 GGTGTCCGTGACTAACTCCAT TGGAAAGGGTAAGACCGTCCT
MIP1alpha CGAGTACCAGTCCCTTTTCTGTTC AAGACTTGGTTGCAGAGTGTCATG
MIP1beta AAGCTGCCGGGAGGTGTAAG TGTCTGCCCTCTCTCTCCTCTTG
IFNalpha1 TCAAAGGACTCATCTGCTGCTTG CCACCTGCTGCATCAGACAAC
CCL5 TTGACCCGTAAATCTGAAGCTAAT TCACAGTCCGAGTCACACTAGTTCAC
OAS1 ATGGAGCACGGACTCAGGA TCACACACGACATTGACGGC
IL10 GGGTTGCCAAGCCTTATCG TCTCACCCAGGGAATTCAAATG
CX3CL1 GGACAACACCATTACTGTGCCTTAG CACACAGGGATGGCTGAGTTCTAC
IP10 CCAAGTGCTGCCGTCATTTTC GGCTCGCAGGGATGATTTCAA
18S GTAACCCGTTGAACCCCATT CCATCCAATCGGTAGTAGCG
IAV segment forward (59 -39) reverse (59 -39)
influenza M AGATGAGTCTTCTAACCGAGGTCG TGCAAAAACATCTTCAAGTCTCTG
Duck gene forward (59 -39) reverse (59 -39)
GAPDH ATGTTCGTGATGGGTGTGAA CTGTCTTCGTGTGTGGCTGT
IL6 GTGCGAGAACAGCATGGAGATG GAATCTGGGATGACCACTTCATC
IFNB CCTCAACCAGATCCAGCATT GGATGAGGCTGTGAGAGGAG
doi:10.1371/journal.ppat.1002186.t001
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PB1-F2 was expressed predominantly in the nucleus, with a few cells
showing diffuse staining of the whole cell body. Remarkably, co-
staining against the NP of influenza virus revealed that only a minor
portion of infected (NP positive) cells showed PB1-F2 staining,
underlining the low expression or stability levels of the PB1-F2
peptide. In agreement with our western blot data, the N66S
substituted PB1-F2 was not detectable at 8 h p.i. However, at 24 h
post infection both WT and N66S variants of PB1-F2 were
detectable, although again not all NP positive cells were positive for
PB1-F2, especially for the N66S mutant (Fig. S1B). At this time
point both variants of PB1-F2 were distributed throughout the
cytoplasm and nucleus. To test if the cytoplasmic PB1-F2 is
Figure 1. Effects of PB1-F2 expression on replication of A/Viet Nam/1203/2004 in murine cells in vitro. A) Time course of viral protein
expression. Murine lung epithelial cells (LA-4) were infected with 2MOI of A/Viet Nam/1203/2004 wild type, dF2 or N66S. Cells were lysed after
indicated time points. Whole cell extracts were analyzed by western blot with specific antibodies against PB1-F2 (upper two panels, short and long
exposure, respectively, PB1-F2 is indicated by black arrows), viral nucleoprotein (NP) or beta-Actin. B) PB1-F2 expression in presence or absence of
10 mM lactocystin. LA4 were infected with 2MOI of A/Viet Nam/1203/2004 wild type, dF2 or N66S. Cells were lysed after 24 h. Whole cell extracts were
analyzed by western blot with specific antibodies against PB1-F2 (upper three panels, short, medium and long exposure, respectively, PB1-F2 is
indicated by black arrows), equal loading is indicated by an unspecific background band (lower panel). C) Polymerase Assay. Murine fibroblasts (3T3)
were transfected with indicated amounts of pCAGGS-PB1 A/Viet Nam/1203/2004 wild type (blue), dF2 (red) or N66S (green) and constant amounts of
PB2, PA, NP and reporter gene expressing plasmids as described in Material and Methods. Mean firefly-luciferase activity of three independent
transfections normalized to renilla-luciferase activity is depicted. Error bars represent SD. No significant differences were detected. D) Multi-cycle
growth curve of A/Viet Nam/1203/2004 wild type (blue), dF2 (red) or N66S (green) on LA-4. Cells were infected with 0.05MOI of virus. Viral
supernatants were taken at the indicated time points. Viral titers were determined by standard plaque assay on MDCK in absence of trypsin. Mean
pfu/ml of independent triplicates6SD indicated by the error bar are depicted. P-values are indicated (*p,0.05) using WT as standard. E) Time course
of viral protein expression in LA-4 (upper panel), bone marrow derived macrophages (BMDM, middle panel) and bone marrow derived dendritic cells
(BMDDC). Cells were infected with 2MOI of A/Viet Nam/1203/2004 wild type, dF2 or N66S and lysed after indicated time points. Whole cell extracts
were analyzed by western blot with specific antibodies against viral nucleoprotein (NP) and tubulin.
doi:10.1371/journal.ppat.1002186.g001
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localized at mitochondria, we co-stained the infected LA-4 cells for
prohibitin, an inner mitochondrial membrane protein. As shown in
Fig. S1C (and enlarged in Fig. S1D), we did not detect predominant
co-localization of PB1-F2WT or N66S with prohibitin, but rather a
diffuse distribution throughout the cytoplasm and nucleus.
N66S Substitution in VN1203 PB1-F2 Reduces Antiviral
Responses in Murine Monocytic Cells
Recent findings implicate an interferon-antagonistic function as
a new role for PB1-F2 during viral infection. Using whole genome
transcriptome analysis, Connenello et al showed increased levels of
type I interferon and interferon stimulated genes (ISGs) in BALB/
c mice infected with a recombinant A/WSN/1933 virus
containing a A/Hong Kong/483/97 PB1 segment with a N66
PB1-F2 substitution, as compared to a virus containing the S66
PB1-F2 [40]. Thus, we tested whether the substitution (N66S) in a
wild type VN1203 H5N1 background would also lead to altered
cellular innate responses in LA-4 cells as well as in BMDMs and
BMDDCs. In all cell types, we could not detect major differences
in the mRNA levels of types I and III interferon induced by
VN1203 WT or dF2 virus. Accordingly, the induction levels of
ISGs (IP10, MxA, ISG15) did not significantly depend on presence
of PB1-F2 (Fig. 2A, B, C). In both BMDMs and BMDDCs, the
dF2 virus induced significantly higher levels of proinflammatory
cytokines IL1beta and IL6. We could not see these differences in
epithelial cells (Fig. 2A). Interestingly, despite higher levels of
replication, the N66S mutant virus clearly induced lower levels of
interferon dependent antiviral responses in BMDMs and
BMDDCs (Fig. 2B and C). Presumably as a consequence of this,
mRNA levels of ISGs and cytokines and chemokines were
significantly reduced in N66S virus infected BMDMs and
BMDDCs. Similar results were seen at early time points of
infection in vivo by Connenello and colleagues [40]. Surprisingly,
this effect was not visible in LA-4 cells, suggesting a monocytic cell
type specific effect of PB1-F2 with regards interferon antagonism.
PB1-F2 N66S Increases Pathogenesis of Highly Virulent
H5N1 in Mice
Next we were interested in determining whether deletion of the
PB1-F2 ORF or the N66S substitution would affect viral
pathogenesis in vivo. The mouse 50% lethal dose (MLD50) of
recombinant WT VN1203 in C57/BL/6 is ,3 pfu (John Steel,
unpublished data). Since we hypothesized that the N66S
substitution might potentially reduce the MLD50, (based on the
higher replication observed in murine lung epithelial cells), we
decided to conduct this experiment in C57/BL/6/A2G-Mx1 mice
that express a functional Mx1 gene product. Previous studies have
shown a dramatically increased resistance of Mx1+/+ mice to both
highly pathogenic avian influenza H5N1 viruses and the 1918
pandemic H1N1 virus [38]. As expected, the MLD50 for
recombinant WT VN1203 was more than 200,000 times higher
in C57/BL/6/A2G-Mx1 mice (MLD50= 6.7610E5 pfu) com-
pared to C57/BL/6 (MLD50= 3.16 pfu) (Fig. 3G). Interestingly,
only animals infected with 2.5610E6 of the wild type virus showed
weight loss and decreased survival (Fig. 3A and D). The mice
infected with lower doses of virus were completely asymptomatic.
Deletion of the PB1-F2 ORF resulted in a slightly decreased
pathogenicity as compared with WT (Fig. 2B, E and G:
MLD50= 1.7610E6 pfu). Interestingly, the N66S substituted virus
showed an increased pathogenicity compared to the wild type
virus (Fig. 3C and F; MLD50 = 1.1610E5 pfu). Moreover, we
observed sustained weight loss, clear signs of sickness (ruffled fur,
lethargy) and death in these animals, even in the groups infected
with 2.5610E4 and 2.5610E3 pfu. Interestingly, in these lower
dose infected animals (2.5610E3 and 2.5610E4) onset of death
occurred unusually late around day 10 post infection. We noted
that prior to death, starting at day 9 post infection, 3 out of 6 mice
infected with 2.5610E3 pfu VN1203 N66S showed neurologic
symptoms (e.g. hemi-paralysis) indicating a potential viral infection
of the central nervous system (CNS). Notably, this was not
observed for the WT or dF2 viruses at any dose used. Also, it was
not observed in animals infected with higher doses of the N66S
virus, likely due to death from pulmonary infection.
Surprisingly, when using a low pathogenic mutant of VN1203
(HAlo) lacking the multi-basic cleavage site, we did not observe
differences in lethality (Fig. 3G right panel) or viral lung titers (data
not shown) between WT, dF2 or N66S viruses. Given that without
the multi-basic cleavage site HAlo viruses are likely to be confined
to the respiratory tract, these data suggest that tissue tropism has a
role in determining the impact of PB1-F2.
PB1-F2 N66S Increases H5N1 Viral Replication and
Neurotropic Spreading in Mice
In the murine lung epithelial cells (LA-4) the N66S virus replicated
to titers 10-fold higher than WT and dF2 (Fig. 1B). Similarly, we
observed almost 100-fold higher titers in N66S virus infected mouse
lungs on days 2 and 5 post infection, as compared to WT and dF2
infected mice (Fig. 4A). The late neurological symptoms observed in
low dose VN1203 N66S virus infected mice suggested spreading of
the virus to the CNS at later stages of infection. We thus conducted a
separate infection study in C57/BL/6/A2G-Mx1 mice using a sub
lethal dose of 2.5610E3 pfu and measured viral titers in the lung,
spleen and brain on day 8 post infection, a day before the onset of
neurological symptoms. At this time-point none of the groups showed
any detectable levels of virus in the lung (data not shown). As
described for highly pathogenic influenza A virus infections in Mx1
positive mice [38], we did not detect systemic spread of WT or dF2
VN1203 into brain or spleen by plaque assay. However, in 6 out of 7
animals infected with N66S virus, we detected virus in the brain
(Fig. 4B), but not in spleen or lung (data not shown), suggesting a
specific function of N66S PB1-F2 in neurotropism. To further show
the replication advantage of the N66S substituted virus in neuronal
tissue, we infected mice intracranially with either 10 or 100 pfu and
measured viral titers in the brain 2 days post infection (Fig. 4C). The
N66S substituted virus replicated significantly better in brain tissue
compared to the WT or dF2 viruses in the mice inoculated with 100
pfu (Fig. 4C lower panel).We even observed replication of N66S virus
in one out of three animals inoculated with 10 pfu. It should be
mentioned that 2 out of 4 animals of the WT infected group showed
viral brain titers, but this difference was not significant compared to
the PB1-F2 deficient virus infected mice.
In summary, substitution of serine for asparagine at position 66
of PB1-F2 enhances replication of VN1203 in murine in vitro
models and reduces the IFN response in infected murine
monocytes. In an in vivo mouse model, this substitution enhances
pathogenicity, replication and neurotropism. However, we could
not detect major differences in viral lung titers and only a mildly
altered LD50 in mice when comparing the WT and PB1-F2
deficient viruses. Nevertheless, we observed enhanced mRNA
levels of the proinflammatory cytokines IL-6 and IL-1b in dF2
virus infected monocytic cells.
Expression of PB1-F2 Does Not Alter Viral Replication in
Duck Cells in vitro
The PB1-F2 ORF is highly conserved in viruses isolated from
ducks. More than 95% of viruses express a PB1-F2 of 87 amino acids
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or longer (NCBI Influenza virus resource: http://www.ncbi.nlm.nih.
gov/genomes/FLU/FLU.html and Influenza Research Database
(IRD): http://www.fludb.org/brc/home.do?decorator= influenza).
We thus hypothesized a specific need to retain PB1-F2 in an avian
host environment and consequently envisaged a different outcome to
our infection study in an avian host as compared to a mammalian
host. To test the growth properties of the three recombinant VN1203
viruses in avian cells we first performed infection experiments in duck
fibroblast cells (DEF). As shown for the murine lung epithelial cells,
the N66S mutant protein was present in lower amounts in infected
cells and expression levels increased in the presence of the proteasome
inhibitor lactocystin (Fig. 5B).
In stark contrast to the murine cell models, we did not observe
any increase in viral replication or viral NP levels by substituting
serine for asparagine at position 66 of VN1203 PB1-F2 (Fig. 5A
and B). Similar to what we observed in the murine lung cell line, in
Figure 2. PB1-F2 alters host response against A/Viet Nam/1203/2004 in murine cells. A–C) LA-4 (A), BMDM (B) and BMDDC (C) were
infected with 2 MOI of A/Viet Nam/1203/2004 wild type (blue), dF2 (red) or N66S (green). Transcriptional response was measured by gene specific
analysis of cDNA amounts from total lysates 8 h post infection. Expression is depicted as mean nfold of mock samples +SD from three independent
samples. P-values are indicated (*p,0.05, ** p,0.01) using WT as standard.
doi:10.1371/journal.ppat.1002186.g002
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the infected DEFs the WT PB1-F2 is expressed to higher levels
(already detectable after 4 h post infection, Fig. 5A), than the
N66S variant (first detectable after 24 h). Interestingly, the N66S
PB1-F2 shows a slower migrating form in western blot, as shown in
murine cells, which may indicate a post-translational modification.
Of note, the proteasome inhibition mainly affected the levels of
low molecular weight PB1-F2, again indicating that the higher
molecular weight form could be protected from degradation
(Fig. 5B).
As shown in LA-4 the polyclonal serum raised against the N-
terminus of PB1-F2 detects a higher migrating band only present
in infected duck cells (24 h post infection).
Next we examined the localization of PB1-F2s in infected DEFs.
The WT PB1-F2 was localized mainly to the nucleus at 8 h pi (Fig.
S2A). Similar to infected LA-4 cells, not all NP positive cells were
also positive for PB1-F2. At 24 h post infection, we could detect
both the WT and the N66S PB1-F2 distributed throughout the
whole cell (Fig. S2B). Co-staining for the mitochondrial protein
prohibitin did not reveal predominant mitochondrial localization
of WT or N66S PB1-F2 (Fig. S2C and enlarged in Fig. S2D) as
observed previously in LA-4 cells. This suggests that the inability of
this PB1-F2 to localize to mitochondria is not a species-specific
phenomenon.
Deletion of PB1-F2 Reduces Pathogenicity of H5N1 in
Ducks
To address a potential impact of PB1-F2 deletion or N66S
substitution in vivo, we next conducted pathogenicity studies in
two-week-old white Peking ducks. The infected ducks were
monitored for clinical signs and scored daily as described
Figure 3. Effects of PB1-F2 expression on viral pathogenesis in vivo. A–C) Weight loss curves of C57/BL/6/A2G-Mx1 mice infected with
indicated doses of A/Viet Nam/1203/2004 wild type (A), dF2 (B) or N66S (C). Animals were excluded from analysis when reaching less than 75% initial
body weight. Mean %-body weight of 5-9 (initial group size) animals normalized to initial weight +SD is depicted. D–F) Survival curves of C57/BL/6/
A2G-Mx1 mice infected with indicated doses of A/Viet Nam/1203/2004 wild type (D), dF2 (E) or N66S (F). %-survival of 5–9 (initial group size) animals
is depicted. (G) MLD50 of A/Viet Nam/1203/2004 wild type, dF2 or N66S (high and low pathogenic version) in C57/BL/6/A2G-Mx1 and C57/BL/6 mice.
doi:10.1371/journal.ppat.1002186.g003
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previously [32,33]. In the first two days of infection, we could
clearly detect differences in the onset of clinical signs between the
three groups of animals (Table 2 and Fig. 6A and B). The WT
virus infected animals show sickness (n = 7) or severe sickness
(n = 3) by day 2 of infection (pathogenicity index (PI) of 2.28). In
contrast the N66S virus infected ducks show a slightly faster
disease progression (day 1: sick n= 9, severely sick n= 1,
(PI = 2.4)). However, both viruses efficiently killed the ducks (9/
10 animals) after 10 days of infection. In contrast, the dF2 virus
infected animals progressed showed significantly slower progres-
sion of clinical signs of sickness (day 2: sick n= 1, (PI = 1.66) as
compared to the WT and N66S virus infection. Furthermore, the
dF2 virus infected animals showed a greater survival rate (3/10),
although this difference is not statistically significant. It has to be
pointed out that all three viruses clearly have a pathogenicity index
of .1.2, defining each as a highly pathogenic virus in birds.
Expression of WT and N66S PB1-F2 Accelerates Systemic
Spreading of VN1203 in Ducks but Does Not Influence
Shedding
To test if PB1-F2 plays a role in viral dissemination to organs in
infected ducks, we measured viral titers in different organs at
various time post infection. By day 1 post infection TCID50 in
colon, liver, spleen and kidney are higher in WT and N66S virus
infected animals compared to dF2 virus infected animals (Fig. 6C).
However, likely due to the use of outbred animals, the variation
within each group was high and by day 3 post infection no
statistically significant differences were detectable (Fig. 6D).
Surprisingly, we did not observe enhanced viral titers in cloacal
swabs of WT or N66S virus infected ducks compared to dF2 virus
infected animals (Fig. 6E and F) implicating similar shedding rates.
In ducks, we could not detect different levels of type I interferon
mRNA on day 1 or 3 post infection in spleen, lung or colon of the
three groups of infected animals (data not shown). Thus it is
possible, at least for VN1203, that PB1-F2 has an interferon-
antagonist independent role in enhancing pathogenicity in avian
hosts.
Overall, we observed that the VN1203 WT and N66S viruses
behave very similarly in ducks with respect to replication and
pathogenicity. Both viruses spread systemically to spleen and
kidney by day 1 post infection and onset of severe clinical signs
occurs by day 1 or 2 post infection. In contrast the deletion of PB1-
F2 resulted in delayed onset of clinical symptoms and systemic
spread of the virus is first detectable only by day 3 post infection.
Our data suggest that the full length PB1-F2 ORF is important for
rapid systemic viral dissemination of HPAIV in birds. This
contrasts with our mammalian host data, in which deletion of PB1-
F2 has only a minor impact on replication and pathogenicity,
although variations at position 66 can enhance virulence.
Discussion
HPAIV infections are associated with hyper-production of
inflammatory cytokines and chemokines, systemic viral spreading
and severe multi-organ damage in both mammalian and avian
hosts. The viral and host factors contributing to this unusually
severe outcome have been studied for years, but are still not
completely identified or understood. Here we analyzed the impact
of PB1-F2, a non-structural viral protein, on viral pathogenesis
and host response in mammalian and avian model systems. PB1-
F2 is present in the majority of avian isolates of all subtypes, but
the full length open reading frame is lost over time in many
mammalian isolates. To our knowledge this is the first comparative
Figure 4. Effects of PB1-F2 expression on viral replication and spreading to the brain in mice. A) C57/BL/6/A2G-Mx1 mice were infected
with 2.5610E6 pfu of VN1203 wild type (blue), dF2 (red) or N66S (green). Viral lung titers were determined on day 2 and 5 post infection in 3 animals
by standard plaque assay on MDCK cells. Titers of individual animals (pfu/ml) are depicted, the detect ion limit of the assay was 50 pfu/ml. P-values for
the mean plaque titers are indicated (*p,0.05) using WT as standard. B) C57/BL/6/A2G-Mx1 mice were infected with 2.5610E3 pfu of VN1203 wild
type (blue), dF2 (red) or N66S (green). Viral brain titers on day 8 post infection of individual animals are depicted. The detection limit of the assay was
50 pfu/ml. C) Direct brain-inoculation of VN1203 wild type (blue), dF2 (red) or N66S (green) (10pfu upper panel, 100pfu lower panel). Viral brain titers
(pfu/ml) 48 h post infection are shown for each animal.
doi:10.1371/journal.ppat.1002186.g004
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study using an iso-genic approach to test the function of PB1-F2 in
a HPAIV in birds and mammals. We further analyzed the impact
of a N66S substitution in PB1-F2, which was previously shown to
be associated with viral pathogenesis of the 1918:H1N1 pandemic
virus [22] and that was recently proposed to promote interferon
antagonistic properties of PB1-F2 in mice [40].
In the murine cell system, the three tested viruses showed
differences in growth and host response depending on the cell
model used. In monocytic cells (BMDMs and BMDDCs) the N66S
substituted virus replicated faster as indicated by higher levels of
NP and induced lower levels of type I interferon, ISGs and
proinflammatory cytokines and chemokines. Interestingly, the
PB1-F2 deleted virus induced higher levels of IL-6 and IL-1beta in
monocytic cells. In contrast, in lung epithelial cells the host
response was similar among the three viruses. A cell type specific
function of PB1-F2 was already proposed when PB1-F2 was
initially described ,10 years ago. Chen et al provided experi-
mental evidence for a pro-apoptotic function of PR8 PB1-F2 that
predominantly affects monocytes [14]. We found that the tested
VN1203 PB1-F2 used in this study does not predominantly
localize to mitochondria. Chen et al showed, that two leucine
residues in the C-terminus of PB1-F2 are essential for mitochon-
drial localization of PB1-F2 (L69 and L75) [39]. They could show
that PB1-F2 of A/Hong Kong/156/1997 does not localize to
mitochondria due to alternative amino acids at position 69 and 75
(Q69 and H75). Interestingly substitution of these residues with
leucine changes the subcellular localization of PB1-F2 to the
mitochondria, but does not affect virus induced apoptosis levels in
vitro or viral pathogenicity in mice when tested in a 7+1 PR8
system with segment 2 of A/Hong Kong/156/1997. Notably,
PB1-F2 of VN1203 does not contain the essential leucines for
mitochondrial localization at position 69 (69Q) and 75 (75R),
which is in full agreement with what we have observed by
immunofluorescence in infected murine and duck cells. It is thus
unclear if VN1203 shares the published pro-apoptotic function of
PB1-F2s from other viruses (e.g. PR8) or if the cytoplasmic PB1-F2
can still interact with mitochondrial host factors such as VDAC
and ANT3 [18].
When PB1-F2 was initially described [14], it was shown that this
short polypeptide is highly unstable and degraded in proteasome
dependent way. We did not observe changes in the levels of WT
PB1-F2 when blocking proteasome function. However, we show
Figure 5. Effects of PB1-F2 expression on replication of A/Viet Nam/1203/2004 in duck fibroblasts in vitro. A) Time course of viral
protein expression. Duck embryonic fibroblasts (DEF) were infected with 2MOI of A/Viet Nam/1203/2004 wild type, dF2 or N66S. Cells were lysed after
indicated time points. Whole cell extracts were analyzed by western blot with specific antibodies against PB1-F2 (upper two panels, short and long
exposure, respectively), viral nucleoprotein (NP) or beta-Actin. B) PB1-F2 expression in presence or absence of 10 mM lactocystin. DEF were infected
with 2MOI of A/Viet Nam/1203/2004 wild type, dF2 or N66S. Cells were lysed after 24 h. Whole cell extracts were analyzed by western blot with
specific antibodies against PB1-F2 (upper three panels, short, medium and long exposure, respectively, PB1-F2 is indicated by black arrows), equal
loading is indicated by GAPDH levels (lower panel). C) Multi-cycle growth curve of A/Viet Nam/1203/2004 wild type (blue), dF2 (red) or N66S (green)
on DEF. Cells were infected with 0.05MOI of virus. Viral supernatants were taken at the indicated time points. Viral titers were determined by standard
plaque assay on MDCK in absence of trypsin. Mean pfu/ml of independent triplicates 6SD indicated by the error bar are depicted.
doi:10.1371/journal.ppat.1002186.g005
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here in murine and duck cells that the protein levels of the N66S
mutant can be increased by exposing the infected cells to
lactocystin. This increase mainly affects the faster migrating
protein species and could implicate that a modified version of PB1-
F2 N66S is protected from proteasomal degradation. At this point
it is unclear if and how the stability of N66S affects its function in
increasing pathogenicity of the virus.
We consistently observed an increase of viral proteins and/or
viral titers in the N66S virus infected murine cells. Mazur et al
have shown that PB1-F2 of PR8 can interact with the polymerase
subunit PB1 and enhance polymerase function. Nevertheless, this
does not affect viral replication and pathogenicity in vitro and in
vivo [20,21]. McAuley et al could show that PB1-F2 of VN1203
can increase the polymerase function of a PR8 derived polymerase
complex in human 293T [21]. However, it did not affect
pathogenesis of a recombinant PR8 with a VN1203 PB1-F2 in
mice. Nevertheless, none of these studies addressed a potential
effect of sequence variations at position 66. In our mouse fibroblast
system (3T3 cells), we did not detect changes in viral polymerase
function in the presence or absence of PB1-F2. Moreover the
N66S substitution did not enhance viral polymerase activity in this
in vitro assay, as could be suspected from the enhanced replication
and enhanced viral protein levels. This is contradictory to the data
presented by McAuley et al. However, it has to be pointed out that
this group combined PR8 polymerase subunits with PB1-F2 from
different viruses [21]. We cannot exclude that the PR8 polymerase
function is specifically modulated by certain PB1-F2s.
We clearly observed enhanced replication of the N66S
substituted virus in vitro and in vivo, resulting in increased
pathogenicity and higher lung titers in mice, consistent with earlier
work using a 7+1 influenza A/WSN/33 virus with an HK/483
PB1 segment [22]. Interestingly, the N66S variant was the only
virus that was able to spread to the CNS of Mx1 positive mice,
leading to detectable viral brain titers 8 days post infection. This
infection of the CNS is most likely responsible for the observed
paralysis in mice infected with low doses of virus and the unusual
second wave of deaths in infected mice around day 10 of infection.
When Mx1 positive mice were initially infected with H5N1 and
the 1918 H1N1 virus [38], no systemic replication could be
detected. We also did not detect systemic viral spreading after
infection with low doses of WT H5N1 virus. Mechanistically it is
not clear at this point how PB1-F2 potentiates spread of the N66S
virus to the central nervous system. It is also intriguing that we
only detected virus in the brain and not in other organs. Direct
viral inoculation of the brain resulted in sustained replication of
the N66S substituted virus, while the WT and dF2 mutant did not
replicate or replicated poorly. This implies that PB1-F2 N66S
supports neuronal dissemination of the virus, and whether this is
due to its specific interaction with a host factor in the brain
remains to determined. Very recently Shinya et al investigated
neuropathogenicity of different H5N1 influenza A virus isolates in
ferrets [41]. Interestingly the authors could show that influenza A/
Hong Kong/483/1997, which contains a serine at position 66 of
PB1-F2 disseminates wider throughout the brain tissue, most likely
by infecting vascular cells, since severe vascular lesions were
observed. These lesions were not found in ferrets infected with a
closely related isolate, A/Hong Kong/486/1997, which contains
an asparagine at positione 66 of PB1-F2. It remains elusive if the
observed phenotype is based on the N66S substitution or other
changes between the two isolates.
To our surprise, we did not observe enhanced viral replication
or pathogenicity of the N66S virus when using a low pathogenic
mutant background of VN1203 lacking the multi-basic cleavage
site in HA. The multi-basic cleavage site is essential for systemic
spreading of HPAIV in mammals, allowing HPAIV to replicate
independently of lung resident extracellular proteases [32]. It
appears then that both a multi-basic cleavage site in HA and a S66
amino-acid residue in PB1-F2 are required to achieve high levels
of replication and spread to the brain in Mx1 competent mice. At
this juncture, we cannot exclude that the enhanced lethality of the
N66S mutant virus and the neurotropism in mice are linked.
Newly developed viral tracking systems, may allow us to find more
details on the type of cells infected by these viruses in vivo [42].
In the Mx1 positive mouse system, the expression of a PB1-F2
with a serine at position 66 clearly enhances viral replication and
pathogenicity in vivo. Interestingly, deletion of the PB1-F2 ORF
had little effect on replication or lethality of the virus, when
compared to the WT virus. This was described earlier for PR8
virus, where the deletion of PB1-F2 did not affect replication and
lethality in mice [24]. In the human H1N1 isolates, the full length
PB1-F2 ORF is lost by introduction of a premature stop codon at
position 59, [25]. This could indicate, that full length PB1-F2 per
se is not essential for viral fitness in humans/mammals and could
explain why the deletion of PB1-F2 had no major effect on
pathogenicity of the viruses tested here and in other studies
[21,24]. Accordingly, the currently circulating swine origin H1N1
virus has no functional PB1-F2 ORF, and is nevertheless spreading
Table 2. Pathogenicity-Index of VN1203 WT, dF2 and N66S in
white peking ducks.
Group 1* 2 3 4 5 6 7 8 9 10 Total Weight Sum Index**
PBS
Healthy 10 10 10 10 10 10 10 10 10 10 100 0 0 0
Sick 0 0 0 0 0 0 0 0 0 0 0 1 0
Severely
sick
0 0 0 0 0 0 0 0 0 0 0 2 0
Dead 0 0 0 0 0 0 0 0 0 0 0 3 0
Total 100 0
WT
Healthy 7 0 0 0 0 0 0 0 0 1 8 0 0 2.28
Sick 3 7 0 2 0 0 0 1 1 0 14 1 14
Severely
sick
0 3 8 5 2 1 1 0 0 0 20 2 40
Dead 0 0 2 3 8 9 9 9 9 9 58 3 174
Total 100 228
dF2
Healthy 9 9 0 0 0 0 0 0 3 3 24 0 0 1.66
Sick 1 1 8 6 5 3 3 3 0 0 30 1 30
Severely
sick
0 0 0 1 0 1 0 0 0 0 2 2 4
Dead 0 0 2 3 5 6 7 7 7 7 44 3 132
Total 100 166
N66S
Healthy 0 0 0 0 0 0 0 0 0 0 0 0 0 2.40
Sick 9 6 0 0 0 0 0 0 0 0 15 1 15
Severely
sick
1 4 8 6 2 2 2 2 2 1 30 2 60
Dead 0 0 2 4 8 8 8 8 8 9 55 3 165
Total 100 240
*days post infection.
**calculated as previously described [32].
doi:10.1371/journal.ppat.1002186.t002
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successfully [26]. At this point, the function of a C-terminally
truncated PB1-F2 in humans remains elusive. PB1-F2 is expressed
from a +1 ORF of segment 2 of IAV. Besides PB1 and PB1-F2 this
segment also encodes for N40, an N-terminally truncated version
of PB1 that was first described in 2009 [43]. Deletion of the PB1-
F2 ORF, by mutation of the start AUG enhances expression of
N40 as a consequence of ribosomal shifting. Deletion of N40
results in attenuation of the virus, but this also changes the PB1
sequence. In contrast, enhanced expression of N40, as shown for
PB1-F2 deficient virus mutants, has no effect on viral replication in
vitro and in ovo [43]. Thus, the function of N40 remains elusive.
We cannot exclude the possibility that in our systems deletion of
the PB1-F2 ORF might cause phenotypes that are indirectly
influenced by the levels of N40.
Despite the lack of differences in replication in vitro and in vivo
or major impact on pathogenicity in mice, we observed increased
mRNA levels of IL1beta and IL6 in murine BMDMs and
BMDDCs infected with PB1-F2 deficient viruses in vitro. So far,
no correlations have been made between PB1-F2 and inflamma-
tory responses. It is striking that this effect is more pronounced in
Figure 6. Diminished pathogenicity of PB1-F2 deficient virus in ducks. Ten 2-week old white Peking ducks were infected with 10E4 pfu of A/
Viet Nam/1203/2004 wild type, dF2 or N66S. A) Three representative pictures of infected ducks were taken on day 4 p.i.. B) Survival curves of 10 2-
week old white peking ducks were infected with 10E4 pfu of A/Viet Nam/1203/2004 wild type (blue), dF2 (red) or N66S (green). Survival (%) is
depicted. C and D) Viral titers of indicated organs from day 1 (C) and day 3 (D) post infection with wild type (blue), dF2 (red) or N66S (green). TCID50/
ml of organs from individual animals are depicted. E) Mean viral titers (TCID50/ml) cloacal swabs from 10 animals per group (initial group size) are
depicted. P-values are indicated (*p,0.05, ** p,0.01) using dF2 as standard.
doi:10.1371/journal.ppat.1002186.g006
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monocytic cells, since these cells have previously been shown to be
more susceptible to the pro-apoptotic function of PB1-F2 [14]. In
contrast to the wildtype and PB1-F2 deficient virus, the N66S virus
induces significantly lower amounts of type I and type III
interferon and consequently ISGs in BMDM and BMDDCs.
Recent work showed that in a WSN/33 virus encoding the HK/
483 PB1, the N66S substitution in the PB1-F2 ORF resulted in
reduced type I interferon levels by day one of infection, despite
higher viral titers [40]. Since pDCs and alveolar macrophages are
the main producers of type I interferon and proinflammatory
cytokines, it is possible that PB1-F2 primarily acts in these cells by
a yet undetermined mechanism. In parallel to this work, a study by
Varga et al (accepted for publication), showed that PB1-F2
expression can decrease RIG-I and MAVS induced IFN-b
production. The detailed mechanism is still unknown, but PB1-
F2 seems to act at the level of MAVS. It is so far unclear to what
extent PB1-F2 contributes to antagonism of the type I interferon
response and why deletion of PB1-F2 (as in the pandemic 2009
H1N1 strains) does not result in diminished viral replication.
In ducks, deletion of PB1-F2 had a more striking effect on
pathogenesis. We clearly observed a delayed onset of clinical
symptoms in the animals infected with the PB1-F2 deficient virus.
Moreover, the systemic spreading of the virus was significantly
delayed, when compared to the wild type and N66S virus.
Nevertheless, the deletion of PB1-F2 did not reduce lethality to the
levels of low pathogenic avian viruses. Moreover, we did not
observe statistically significant differences in the type I interferon
levels present in infected animals. Although this could be a
consequence of the high inner group variation, due to the
outbread nature of the animals, it may also be that the proposed
anti-interferon function of PB1-F2 is specific for mammals. We are
currently testing this hypothesis.
We also did not see major differences in viral loads in the cloacal
swabs of these animals, indicating that PB1-F2 does not affect viral
shedding. A recent study by Marjuki et al has shown that three
point mutations in PB1-F2 of VN1203 can affect polymerase
function in chicken cells and pathogenicity in mallard ducks [37].
Interestingly, these three mutations change the PB1-F2 of the
highly pathogenic VN1203 into the PB1-F2 of the low pathogenic
A/chicken/Vietnam/C58/04. The same group showed in a
previous study that the PB1 segment essentially contributes to
pathogenicity of VN1203 in birds [44]. Taken together, these data
and our data imply that PB1-F2 is important for the pathogenicity
of H5N1 HPAIV. Moreover, the high conservation of PB1-F2 in
avian isolates suggests a yet to be determined, but essential,
function of PB1-F2 for these viruses.
It is intriguing that the N66S substitution of PB1-F2, a
polymorphism associated with increased pathogenicity of the
1918 H1N1 and the highly pathogenic H5N1 isolates from Hong
Kong 1997, significantly enhances the pathogenicity of VN1203 in
mice, but has little detectable effect in ducks. Intriguingly, in many
avian isolates the serine at position 66 is common. This could
mean that the molecular mechanism for the enhanced pathoge-
nicity of viruses with this substitution in mammals does not apply
to avian hosts.
In summary, our study shows that PB1-F2 is an important,
evolutionary conserved pathogenicity factor of HPAIV in avian
species that supports faster viral spreading into different organs. In
mammals the 1918:H1N1-like N66S substitution supports spread-
ing and replication in the CNS, by a yet to be defined mechanism.
The increase in viral pathogenicity of N66S mutant is possibly due
to inhibition of type I interferon and proinflammatory responses in
monocytic cells.
Supporting Information
Figure S1 Subcellular localization of PB1-F2 in LA-4
during viral infection. LA-4 were infected for 8h (A) or 24h (B)
with 2 MOI of A/Viet Nam/1203/2004 wild type, dF2 or N66S.
Nuclei were stained with DAPI (blue), PB1-F2 was stained with a
polyclonal rabbit serum and anti rabbit-Alexa-488 (green) and NP
was stained with a monoclonal mouse antibody and anti-mouse-
Alexa-555 (red). Merged pictures are shown in the right panel. All
pictures were taken with a 40x objective using identical exposure
settings for the green and red channel. Representative cells are
shown. C) LA-4 were infected for 24h as described for A/B. Nuclei
were stained with DAPI (blue), PB1-F2 was stained with a
polyclonal rabbit serum and anti rabbit-Alexa-488 (green) and
prohibitin was stained with a monoclonal mouse antibody and
anti-mouse-Alexa-555 (red). All pictures were taken with a 63x
objective using identical exposure settings for the green and red
chanel. D) enlarged version of VN1203 WT and N66S from Fig.
S1C.
(TIFF)
Figure S2 Subcellular localization of PB1-F2 in duck
embryonic fibroblasts during viral infection. DEF were
infected for 8h (A) or 24h (B) with 2 MOI of A/Viet Nam/1203/
2004 wild type, dF2 or N66S. Nuclei were stained with DAPI
(blue), PB1-F2 was stained with a polyclonal rabbit serum and anti
rabbit-Alexa-488 (green) and NP was stained with a monoclonal
mouse antibody and anti-mouse-Alexa-555 (red). Merged pictures
are shown in the right panel. All pictures were taken with a 40x
objective using identical exposure settings for the green and red
channel. Representative cells are shown. C) DEF were infected for
24h as described for A/B. Nuclei were stained with DAPI (blue),
PB1-F2 was stained with a polyclonal rabbit serum and anti
rabbit-Alexa-488 (green) and prohibitin was stained with a
monoclonal mouse antibody and anti-mouse-Alexa-555 (red). All
pictures were taken with a 63x objective using identical exposure
settings for the green and red chanel. D) enlarged version of
VN1203 WT and N66S from Fig. S2C.
(TIFF)
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